A detailed history of Castlekeep Investment Advisors LLC transactions in Novartis Ag stock. As of the latest transaction made, Castlekeep Investment Advisors LLC holds 1,127,726 shares of NVS stock, worth $120 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
1,127,726
Previous 10,051 11120.04%
Holding current value
$120 Million
Previous $1.07 Billion 21648.25%
% of portfolio
0.62%
Previous 0.83%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$96.78 - $117.18 $108 Million - $131 Million
1,117,675 Added 11120.04%
1,127,726 $233 Billion
Q2 2024

Feb 14, 2025

SELL
$92.57 - $107.37 $2,591 - $3,006
-28 Reduced 0.28%
10,051 $1.07 Billion
Q1 2024

Feb 14, 2025

SELL
$95.27 - $108.47 $101,843 - $115,954
-1,069 Reduced 9.59%
10,079 $975 Million
Q4 2023

Feb 14, 2025

BUY
$92.27 - $101.54 $1.03 Million - $1.13 Million
11,148 New
11,148 $1.13 Billion

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $229B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Castlekeep Investment Advisors LLC Portfolio

Follow Castlekeep Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castlekeep Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castlekeep Investment Advisors LLC with notifications on news.